Barclays »

Viracta Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Viracta Therapeutics (VIRX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Viracta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viracta Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viracta Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0k 2.7k 0.75
2023-09-30 $3.0k 2.7k 1.12
2023-06-30 $4.0k 2.7k 1.50
2023-03-31 $4.0k 2.7k 1.50
2022-12-31 $4.0k 2.8k 1.45
2022-09-30 $20k 4.8k 4.13
2022-06-30 $10k 2.7k 3.75
2022-03-31 $41k 8.6k 4.79